Loading...
Acute brain dysfunction (ABD) often occurs in critically ill hospitalized patients and is an independent risk factor for prolonged length of stay, greater neurologic dysfunction, and short-term mortality. Benzodiazepines, the most commonly used sedating drugs, potentiate risk for ABD by activating γ-aminobutyric acid (GABAA) central nervous system receptors.
In the partially industry-supported, double-blind MEND (Maximizing Efficacy of targeted sedation and reducing Neurological Dysfunction) study, U.S. researchers compared a novel sedative analgesic medication, dexmedetomidine (Precedex; a highly selective α2-adrenergic–receptor agonist), with a currently recommended agent, lorazepam, in 106 mechanically ventilated adult patients from two t…